T. forsythia is enriched in the gut of patients with periodontitis
The study starts from a clinical comparison rather than from mice. It recruited 50 people with liver fibrosis, 23 with periodontal health and 27 with periodontitis, and sequenced fecal bacterial communities in 30 of them. Overall diversity did not differ significantly between groups, but community composition did: the periodontitis group showed a distinct clustering pattern and shifts in which bacteria were abundant.
Screening that comparison flagged two candidate periodontal pathogens, Rothia mucilaginosa and T. forsythia. Because 16S rRNA sequencing is limited for species-level identification, the authors confirmed both by qPCR, which showed significantly higher gut abundance in the periodontitis-plus-fibrosis group than in the periodontal-health-plus-fibrosis group. Two other "red complex" members, Porphyromonas gingivalis and Treponema denticola, showed no significant difference between groups.
The distinguishing result is the correlation: gut abundance of T. forsythia, but not R. mucilaginosa, was positively correlated with FIB-4 scores, an index of fibrosis severity. This is an association in a modest clinical sample, not proof that the bacterium causes worse fibrosis in people. It does, however, tell the authors which organism to test experimentally.
Only T. forsythia worsened fibrosis in the mouse model
To move from correlation to causation, the authors used mice with carbon tetrachloride (CCl4)-induced liver fibrosis and gave live bacteria by oral gavage. Adding T. forsythia worsened the fibrotic phenotype: mice gained less body weight, had higher serum AST and ALT, and showed more collagen deposition on Masson and Sirius red staining than CCl4-only mice. The liver-to-body weight ratio, by contrast, did not differ significantly between those two groups.
The molecular readouts pointed the same way. Liver expression of Col1a1, Acta2, Timp1 and Tgf-β rose, and protein levels of α-SMA and Collagen I increased, with immunofluorescence confirming more α-SMA in liver sections. Blood pro-inflammatory cytokines and liver reactive oxygen species were also elevated, so the aggravation came with more inflammation and oxidative stress.
The comparison that matters is internal: R. mucilaginosa inoculation did not significantly accelerate disease progression relative to CCl4 alone. Being enriched in patients was therefore not sufficient; only T. forsythia reproduced the worsening in vivo.
Live bacteria, not heat-killed ones, break the intestinal barrier
The proposed route from mouth to liver runs through a leaky gut. After oral gavage, T. forsythia DNA peaked at 24–36 hours and remained detectable up to 72 hours. In infected fibrotic mice, the tight-junction proteins ZO-1 and Occludin fell at both mRNA and protein levels, the intestinal epithelium showed structural damage, and mucin production decreased.
A functional permeability test supported the structural findings. After oral FITC-dextran, the signal in the CCl4 plus T. forsythia group was no longer confined to the intestinal lumen and appeared diffuse; after intravenous injection, serum FITC-dextran was markedly higher at 4 hours. Liver LPS was also significantly elevated, consistent with bacterial products reaching the liver through a compromised barrier.
Bacterial viability was required. Heat-killed T. forsythia did not change ZO-1 or Occludin, did not cause obvious intestinal damage or mucin loss, and did not increase FITC-dextran leakage. This separates the barrier effect from mere exposure to bacterial components and is one of the paper's cleaner mechanistic controls.
An ICAM-1⁺ neutrophil subset expands in fibrotic liver
With the barrier breached, the authors asked which immune cells change in the liver. Flow cytometry showed significantly more neutrophils and macrophages in CCl4 plus T. forsythia mice than in CCl4 mice, while Th17, Treg and Th1 proportions did not differ significantly. Immunohistochemistry confirmed more Ly6G⁺ neutrophils.
To resolve neutrophil states, the team reanalyzed a public single-cell RNA-seq dataset of mouse fibrotic liver (GSE218496). Neutrophils split into three transcriptionally distinct subpopulations, and the ICAM1⁺IL1b⁺ subset was selectively expanded in fibrotic liver. Cell–cell interaction analysis predicted enhanced neutrophil–hepatic stellate cell signaling. A human periodontitis single-cell dataset (GSE164241) also contained an ICAM1-enriched neutrophil population, linking the finding back to periodontal tissue.
ICAM-1 here is an adhesion molecule used to define this neutrophil state, not a marker of fibrosis itself. The authors further report that the ICAM-1⁺ neutrophil proportion was elevated through the TLR4/NF-κB pathway, which they connect to microbial translocation after barrier disruption. That pathway link is the authors' interpretation of their data rather than a separately isolated step.
Neutrophil TNF-α activates stellate cells through PI3K/AKT/mTOR
The proposed effector is TNF-α. ICAM-1⁺ neutrophils were found to secrete TNF-α, which the authors show activates the PI3K/AKT/mTOR pathway in hepatic stellate cells. Stellate cell activation is the step that converts chronic injury into collagen deposition, so this pathway is the mechanistic bridge between immune infiltration and fibrosis.
Two genetic tests support the chain. Conditional knockout of ICAM-1 specifically in neutrophils significantly attenuated the inflammatory response and liver fibrosis caused by T. forsythia. Global deletion of TNF-α likewise reduced fibrosis and inhibited PI3K/mTOR pathway activation. An indirect co-culture of ICAM-1⁺ neutrophils and stellate cells provided in vitro support for the interaction.
These loss-of-function results are the strongest causal evidence in the paper. They show that both the ICAM-1⁺ neutrophil population and TNF-α are needed for T. forsythia to worsen fibrosis in this model, rather than merely accompanying it.
The oral-gut-liver axis holds within defined limits
The authors describe the result as an oral-gut-liver axis driven by T. forsythia and propose targeting the oral microbiota or the TNF-α pathway for periodontitis-related fibrosis. That framing is supported by the combination of human correlation, mouse gain-of-function with live bacteria, and two loss-of-function genetic tests.
The limits are specific. The authors state that the mechanism by which T. forsythia increases ICAM-1⁺ neutrophils remains unclear, and that other factors such as gut microbiota variation and host immune response were not addressed. The animal model may not fully replicate human periodontal disease and its effect on liver fibrosis, so clinical validation is still needed. The human evidence is correlational and comes from 50 patients, 30 of whom were sequenced.
The paper also notes that neutrophils have been reported both to promote and to limit liver fibrosis, with effects depending on disease stage. Its contribution is not that neutrophils are uniformly harmful, but that a particular ICAM-1⁺ subset releasing TNF-α is the pro-fibrotic arm in this T. forsythia model.
Why T. forsythia outranks its red-complex partners here
The most decision-relevant comparison in this paper is between pathogens, not between pathways. P. gingivalis has dominated prior work on periodontal pathogens in extra-oral disease, yet in this cohort its gut abundance did not differ significantly between periodontitis and periodontal-health patients, and neither did T. denticola's. R. mucilaginosa was enriched but failed to worsen fibrosis in mice.
T. forsythia was the only candidate that satisfied all three filters: gut enrichment in patients with periodontitis, a positive correlation with FIB-4, and aggravation of fibrosis in vivo that depended on live bacteria, ICAM-1⁺ neutrophils and TNF-α. For readers weighing microbial targets in periodontitis-related liver disease, that combination makes T. forsythia the priority this study identifies, while the TNF-α–PI3K/AKT/mTOR step in stellate cells is the more directly testable therapeutic node.
Sources used in this answer
Periodontal pathogen Tannerella forsythia promotes liver fibrosis via ICAM-1⁺ neutrophil–dependent hepatic stellate cell activation
Gut-enriched T. forsythia worsened CCl4-induced liver fibrosis in mice by disrupting the intestinal barrier and expanding ICAM-1⁺ neutrophils that secrete TNF-α and activate PI3K/AKT/mTOR in hepatic stellate cells; deleting neutrophil ICAM-1 or TNF-α attenuated the effect.
